| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 6989 | 2008 |
| MDS clinical diagnostic criteria for Parkinson's disease RB Postuma, D Berg, M Stern, W Poewe, CW Olanow, W Oertel, J Obeso, ... Movement disorders 30 (12), 1591-1601, 2015 | 6534 | 2015 |
| Parkinson's disease LV Kalia, AE Lang The Lancet 386 (9996), 896-912, 2015 | 6164 | 2015 |
| Parkinson disease W Poewe, K Seppi, CM Tanner, GM Halliday, P Brundin, J Volkmann, ... Nature reviews Disease primers 3 (1), 1-21, 2017 | 5042 | 2017 |
| Parkinson's disease AE Lang, AM Lozano New England Journal of Medicine 339 (16), 1130-1143, 1998 | 3869 | 1998 |
| Phenomenology and classification of dystonia: a consensus update A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ... Movement disorders 28 (7), 863-873, 2013 | 2476 | 2013 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2357 | 2004 |
| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ... New England Journal of Medicine 361 (17), 1651-1661, 2009 | 2350 | 2009 |
| A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang New England Journal of Medicine 342 (20), 1484-1491, 2000 | 2029 | 2000 |
| Pharmacological treatment of Parkinson disease: a review BS Connolly, AE Lang Jama 311 (16), 1670-1683, 2014 | 1970 | 2014 |
| Consensus statement on the diagnosis of multiple system atrophy S Gilman, P Low, N Quinn, A Albanese, Y Ben-Shlomo, C Fowler, ... Clinical autonomic research 8, 359-362, 1998 | 1953 | 1998 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 1930 | 2017 |
| Criteria for the diagnosis of corticobasal degeneration MJ Armstrong, I Litvan, AE Lang, TH Bak, KP Bhatia, B Borroni, AL Boxer, ... Neurology 80 (5), 496-503, 2013 | 1804 | 2013 |
| Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients D Weintraub, J Koester, MN Potenza, AD Siderowf, M Stacy, V Voon, ... Archives of neurology 67 (5), 589-595, 2010 | 1744 | 2010 |
| Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ... The Lancet Neurology 7 (7), 583-590, 2008 | 1723 | 2008 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ... Movement disorders 22 (1), 41-47, 2007 | 1620 | 2007 |
| MDS research criteria for prodromal Parkinson's disease D Berg, RB Postuma, CH Adler, BR Bloem, P Chan, B Dubois, T Gasser, ... Movement Disorders 30 (12), 1600-1611, 2015 | 1439 | 2015 |
| Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease Deep-Brain Stimulation for Parkinson's Disease Study Group New England Journal of Medicine 345 (13), 956-963, 2001 | 1378 | 2001 |
| Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up MC Rodriguez-Oroz, JA Obeso, AE Lang, JL Houeto, P Pollak, ... Brain 128 (10), 2240-2249, 2005 | 1335 | 2005 |
| Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow AE Taylor, JA Saint-Cyr, AE Lang Brain 109 (5), 845-883, 1986 | 1237 | 1986 |
